Application | Comment | Organism |
---|---|---|
medicine | inhibition of soluble epoxide hydrolase by orally active inhibitor 12-(3-adamantan-1-yl-ureido)-dodecanoic acid is effective in persistently reducing blood pressure in female spontaneously hypertensive rats when 12-(3-adamantan-1-yl-ureido)-dodecanoic acid is applied during the perinatal phase. This is accompanied by marked increases in major renal arachidonic acid epoxides and decreases in renal lipoxygenase products of arachidonic acid. Early inhibition of SEH induces a delayed increase in renal 5-HETE at 24 weeks, in contrast to a decrease at 2 weeks. Inhibition of SEH in female spontaneously hypertensive rats from 8 to 12 weeks does not reduce blood but causes profound decreases in renal 15(S)-HETrE, LTB4, TBX2, 5-HETE, and 20-HETE and increases in TriHOMEs. In male spontaneously hypertensive rats, blood pressure reduction after perinatal AUDA is transient | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
12-(3-adamantan-1-yl-ureido)-dodecanoic acid | orally active inhibitor. Inhibition of soluble epoxide hydrolase is effective in persistently reducing blood pressure in female spontaneously hypertensive rats when 12-(3-adamantan-1-yl-ureido)-dodecanoic acid is applied during the perinatal phase | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
spontaneously hypertensive rats | - |
Source Tissue | Comment | Organism | Textmining |
---|
Synonyms | Comment | Organism |
---|---|---|
SEH | - |
Rattus norvegicus |